• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Phosphorylation of the alpha- and beta-isoforms of DNA topoisomerase II is qualitatively different in interphase and mitosis in Chinese hamster ovary cells.

作者信息

Burden D A, Sullivan D M

机构信息

Department of Medicine, James Graham Brown Cancer Center, University of Louisville, Kentucky 40292.

出版信息

Biochemistry. 1994 Dec 13;33(49):14651-5. doi: 10.1021/bi00253a001.

DOI:10.1021/bi00253a001
PMID:7993892
Abstract

Qualitative differences between interphase and mitotic topoisomerase II were studied in Chinese hamster ovary cells. Differences in sites of phosphorylation of in vivo 32P-labeled topoisomerase II alpha were observed between mitosis and interphase by one-dimensional phosphopeptide mapping of partial tryptic digests. Two-dimensional phosphopeptide mapping of complete trypsin digests revealed two phosphopeptides unique to interphase and three phosphopeptides unique to mitosis. A reduced electrophoretic mobility on denaturing gels (approximately 190 kDa) was observed for the beta-isoform of topoisomerase II in mitosis relative to interphase. Treatment of lysates with alkaline phosphatase demonstrated that this was due to phosphorylation of mitotic topoisomerase II beta. The existence of interphase- and mitosis-specific sites of phosphorylation of topoisomerase II alpha, along with the electrophoretic mobility shift caused by phosphorylation of topoisomerase II beta in mitosis, demonstrates qualitative differences between interphase and mitosis in the phosphorylation state of both isoforms of topoisomerase II.

摘要

相似文献

1
Phosphorylation of the alpha- and beta-isoforms of DNA topoisomerase II is qualitatively different in interphase and mitosis in Chinese hamster ovary cells.
Biochemistry. 1994 Dec 13;33(49):14651-5. doi: 10.1021/bi00253a001.
2
Human topoisomerase II alpha is phosphorylated in a cell-cycle phase-dependent manner by a proline-directed kinase.人类拓扑异构酶IIα被一种脯氨酸导向激酶以细胞周期阶段依赖性方式磷酸化。
Eur J Biochem. 1995 Jul 15;231(2):491-7. doi: 10.1111/j.1432-1033.1995.tb20723.x.
3
Spectrin redistributes to the cytosol and is phosphorylated during mitosis in cultured cells.血影蛋白重新分布到细胞质中,并在培养细胞的有丝分裂过程中发生磷酸化。
J Cell Biol. 1992 Dec;119(6):1559-72. doi: 10.1083/jcb.119.6.1559.
4
Cell cycle phase-specific phosphorylation of human topoisomerase II alpha. Evidence of a role for protein kinase C.
J Biol Chem. 1995 Nov 24;270(47):28357-63. doi: 10.1074/jbc.270.47.28357.
5
Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.I型和II型拓扑异构酶的细胞周期偶联重定位及催化酶活性的调节
J Cell Biol. 1997 Feb 24;136(4):775-88. doi: 10.1083/jcb.136.4.775.
6
Cell-specific phosphorylation of H1 histone subtypes among different Chinese hamster cell lines in interphase.间期不同中国仓鼠细胞系中H1组蛋白亚型的细胞特异性磷酸化。
J Biol Chem. 1982 Feb 10;257(3):1247-52.
7
DNA topoisomerase II is required for formation of mitotic chromosomes in Chinese hamster ovary cells: studies using the inhibitor 4'-demethylepipodophyllotoxin 9-(4,6-O-thenylidene-beta-D-glucopyranoside).DNA拓扑异构酶II在中国仓鼠卵巢细胞有丝分裂染色体形成中是必需的:使用抑制剂4'-去甲基表鬼臼毒素9-(4,6-O-亚噻吩基-β-D-吡喃葡萄糖苷)的研究
Biochemistry. 1990 Oct 16;29(41):9531-7. doi: 10.1021/bi00493a006.
8
Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II.中国仓鼠卵巢细胞拓扑异构酶II的细胞周期依赖性磷酸化及活性
Biochem J. 1993 Jul 1;293 ( Pt 1)(Pt 1):297-304. doi: 10.1042/bj2930297.
9
Cell cycle-specific and transcription-related phosphorylation of mammalian topoisomerase I.哺乳动物拓扑异构酶I的细胞周期特异性及转录相关磷酸化作用
Exp Cell Res. 1995 Mar;217(1):125-31. doi: 10.1006/excr.1995.1071.
10
Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.对拓扑异构酶II催化抑制剂ICRF-159具有抗性的中国仓鼠卵巢细胞:Tyr49Phe突变赋予对双二氧哌嗪的高水平抗性。
Cancer Res. 1998 Apr 1;58(7):1460-8.

引用本文的文献

1
DNA-Stimulated Liquid-Liquid phase separation by eukaryotic topoisomerase ii modulates catalytic function.真核拓扑异构酶 II 通过 DNA 刺激液-液相分离调节催化功能。
Elife. 2022 Nov 7;11:e81786. doi: 10.7554/eLife.81786.
2
Post-translational modifications in DNA topoisomerase 2α highlight the role of a eukaryote-specific residue in the ATPase domain.DNA 拓扑异构酶 2α 的翻译后修饰突出了在 ATP 酶结构域中一个真核生物特有残基的作用。
Sci Rep. 2018 Jun 18;8(1):9272. doi: 10.1038/s41598-018-27606-8.
3
The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells.
拓扑异构酶 II 的 α 异构体对于人类细胞有丝分裂染色体的超螺旋化是必需的。
Nucleic Acids Res. 2014 Apr;42(7):4414-26. doi: 10.1093/nar/gku076. Epub 2014 Jan 29.
4
Mechanisms regulating resistance to inhibitors of topoisomerase II.调控拓扑异构酶 II 抑制剂耐药性的机制。
Front Pharmacol. 2013 Aug 1;4:89. doi: 10.3389/fphar.2013.00089. eCollection 2013.
5
Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.酪蛋白激酶Iδ/ε使拓扑异构酶IIα的丝氨酸-1106位点磷酸化,并调节DNA切割活性。
Nucleic Acids Res. 2009 Feb;37(2):382-92. doi: 10.1093/nar/gkn934. Epub 2008 Nov 29.
6
Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase I.有丝分裂磷酸化刺激人拓扑异构酶I的DNA松弛活性。
J Biol Chem. 2008 Jun 13;283(24):16711-22. doi: 10.1074/jbc.M802246200. Epub 2008 Apr 11.
7
Multiple forms of cardiac myosin-binding protein C exist and can regulate thick filament stability.存在多种形式的心肌肌球蛋白结合蛋白C,它们可以调节粗肌丝的稳定性。
J Gen Physiol. 2007 May;129(5):419-28. doi: 10.1085/jgp.200609714.
8
Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.细胞外信号调节激酶通过一种独立于磷酸化的机制激活拓扑异构酶IIα。
Mol Cell Biol. 1999 May;19(5):3551-60. doi: 10.1128/MCB.19.5.3551.
9
Method for quantifying expression of functionally active topoisomerase II in patients with leukaemia.白血病患者中功能性活性拓扑异构酶II表达的定量方法。
J Clin Pathol. 1996 Oct;49(10):848-52. doi: 10.1136/jcp.49.10.848.